Repare Therapeutics Stock Market Value
| RPTX Stock | USD 2.81 0.16 5.39% |
| Symbol | Repare |
Repare Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repare Therapeutics. If investors know Repare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repare Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.99) | Revenue Per Share 1.572 | Quarterly Revenue Growth (0.96) | Return On Assets (0.23) | Return On Equity (0.41) |
The market value of Repare Therapeutics is measured differently than its book value, which is the value of Repare that is recorded on the company's balance sheet. Investors also form their own opinion of Repare Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Repare Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repare Therapeutics' market value can be influenced by many factors that don't directly affect Repare Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repare Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Repare Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repare Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Repare Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Repare Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Repare Therapeutics.
| 12/05/2022 |
| 11/24/2024 |
If you would invest 0.00 in Repare Therapeutics on December 5, 2022 and sell it all today you would earn a total of 0.00 from holding Repare Therapeutics or generate 0.0% return on investment in Repare Therapeutics over 720 days. Repare Therapeutics is related to or competes with Accolade, Nurix Therapeutics, 908 Devices, and Relay Therapeutics. Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its ... More
Repare Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Repare Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Repare Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.71 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 25.67 | |||
| Value At Risk | (6.43) | |||
| Potential Upside | 7.96 |
Repare Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Repare Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Repare Therapeutics' standard deviation. In reality, there are many statistical measures that can use Repare Therapeutics historical prices to predict the future Repare Therapeutics' volatility.| Risk Adjusted Performance | 0.0102 | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.70) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0011 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Repare Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Repare Therapeutics Backtested Returns
Repare Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0194, which implies the firm had a -0.0194% return per unit of risk over the last 3 months. Repare Therapeutics exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Repare Therapeutics' Semi Deviation of 3.51, risk adjusted performance of 0.0102, and Coefficient Of Variation of 40232.04 to confirm the risk estimate we provide. The company holds a Beta of 1.0, which implies a somewhat significant risk relative to the market. Repare Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Repare Therapeutics is expected to follow. At this point, Repare Therapeutics has a negative expected return of -0.0862%. Please make sure to check Repare Therapeutics' expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to decide if Repare Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.54 |
Modest predictability
Repare Therapeutics has modest predictability. Overlapping area represents the amount of predictability between Repare Therapeutics time series from 5th of December 2022 to 30th of November 2023 and 30th of November 2023 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Repare Therapeutics price movement. The serial correlation of 0.54 indicates that about 54.0% of current Repare Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.54 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 2.28 |
Repare Therapeutics lagged returns against current returns
Autocorrelation, which is Repare Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Repare Therapeutics' stock expected returns. We can calculate the autocorrelation of Repare Therapeutics returns to help us make a trade decision. For example, suppose you find that Repare Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Repare Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Repare Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Repare Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Repare Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Repare Therapeutics Lagged Returns
When evaluating Repare Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Repare Therapeutics stock have on its future price. Repare Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Repare Therapeutics autocorrelation shows the relationship between Repare Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Repare Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Repare Stock Analysis
When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.